condyloma acuminatum and acne
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Clinical diagnosed with condyloma acuminatum or acne, aged > 18 years; 2. All patients voluntarily participate in the study, actively cooperate with the treatment and ability to understand and the willingness to sign a written informed consent. Patients are willing to pay for the treatment, and agreed to take a picture of the skin lesions.
Exclusion criteria
Exclusion criteria: 1. Those who have been treated with ALA-PDT and those who have applied any other impact study within 12 weeks; 2. Patients with other diseases that may affect the efficacy evaluation, such as other light skin diseases; 3. Patients taking phototoxic or photosensitive drugs within 12 weeks; 4. Patients with severe immune dysfunction; 5. Patients with scar constitution; 6. Patients with known skin photoallergy, porphyria or allergy to Ala, light or lidocaine; 7. Those who suffer from serious internal diseases, psychological and mental diseases, infectious diseases or pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete clearance rate of condyloma acuminatum lesions;complete clearance rate of acne lesions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain assessment;Recurrence rate of lesions; | — |
Countries
China
Contacts
The Affiliated Hospital of Xuzhou Medical University